What does Dr. DE CALUWE & ABURN, huisartsen do?

Dr. DE CALUWE & ABURN, huisartsen is a general practice in Stekene. Private Limited, started on 22 December 1992, 1 establishment.

What is the address of Dr. DE CALUWE & ABURN, huisartsen?

The registered office of Dr. DE CALUWE & ABURN, huisartsen is located at Dorpsstraat(STE) 70, 9190 Stekene.

Is Dr. DE CALUWE & ABURN, huisartsen still active?

Yes. According to the CBE (31 October 2026) Dr. DE CALUWE & ABURN, huisartsen is active, legal situation “Normale toestand”, started on 22 December 1992.

Is Dr. DE CALUWE & ABURN, huisartsen registered on Peppol?

Yes, Dr. DE CALUWE & ABURN, huisartsen is registered on the Peppol network with ID 0208:0449126430.

What is the enterprise number of Dr. DE CALUWE & ABURN, huisartsen?

The enterprise number of Dr. DE CALUWE & ABURN, huisartsen is BE0449126430.

When was Dr. DE CALUWE & ABURN, huisartsen founded?

Dr. DE CALUWE & ABURN, huisartsen was founded on 22 December 1992.

Who are the directors of Dr. DE CALUWE & ABURN, huisartsen?

According to the 2025 annual accounts, the directors of Dr. DE CALUWE & ABURN, huisartsen are: Gillian Aburn, Pieter De Caluwé.

Is Dr. DE CALUWE & ABURN, huisartsen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 1992; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. DE CALUWE & ABURN, huisartsen make in 2025?

Dr. DE CALUWE & ABURN, huisartsen posted a profit after taxes of € 317,920 in financial year 2025.

What is the revenue of Dr. DE CALUWE & ABURN, huisartsen?

As a small company, Dr. DE CALUWE & ABURN, huisartsen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 499,323.

Dr. DE CALUWE & ABURN, huisartsen (Private Limited)

Dossier Dr. DE CALUWE & ABURN, huisartsen, printed on 31 October 2026 from databakkes.be/en/0449126430/dr-de-caluwe-aburn-huisartsen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. DE CALUWE & ABURN, huisartsen from Stekene, company number BE0449126430, closed financial year 2025 with a result of € 317,920 after tax. For that financial year Dr. DE CALUWE & ABURN, huisartsen recorded a gross margin of € 499,323 and equity of € 1.9 million. Compared with financial year 2024, the result moved from € 300,569 to € 317,920. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 18, 2026.

What it is worth Growing

€ 1.9 million

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 317,920

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.3 million

▲ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.8 million.

People and assets in 2025

Wage cost

€ 260

▲ 160% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 10,113

▼ 28% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 155,205

▼ 11% vs 2024

€ 20,160 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 7,977

▲ 50% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 53,314

▲ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 354,976 Gross margin 2022: € 354,976 First fiscal year in the series	€ 459,131 Gross margin 2023: € 459,131 ▲ 29% vs 2022 (€ 354,976) Favourable step	€ 463,059 Gross margin 2024: € 463,059 ▲ 1% vs 2023 (€ 459,131) Favourable step	€ 499,323 Gross margin 2025: € 499,323 ▲ 8% vs 2024 (€ 463,059) Favourable step	▲ 8%
Profit after taxes	€ 189,737 Profit after taxes 2022: € 189,737 First fiscal year in the series	€ 266,407 Profit after taxes 2023: € 266,407 ▲ 40% vs 2022 (€ 189,737) Favourable step	€ 300,569 Profit after taxes 2024: € 300,569 ▲ 13% vs 2023 (€ 266,407) Favourable step	€ 317,920 Profit after taxes 2025: € 317,920 ▲ 6% vs 2024 (€ 300,569) Favourable step	▲ 6%
Equity	€ 1,116,029 Equity 2022: € 1,116,029 First fiscal year in the series	€ 1,357,936 Equity 2023: € 1,357,936 ▲ 22% vs 2022 (€ 1,116,029) Favourable step	€ 1,533,005 Equity 2024: € 1,533,005 ▲ 13% vs 2023 (€ 1,357,936) Favourable step	€ 1,850,925 Equity 2025: € 1,850,925 ▲ 21% vs 2024 (€ 1,533,005) Favourable step	▲ 21%
Total debts	€ 308,343 Total debts 2022: € 308,343 First fiscal year in the series	€ 254,585 Total debts 2023: € 254,585 ▼ 17% vs 2022 (€ 308,343) Favourable step	€ 247,918 Total debts 2024: € 247,918 ▼ 3% vs 2023 (€ 254,585) Favourable step	€ 238,508 Total debts 2025: € 238,508 ▼ 4% vs 2024 (€ 247,918) Favourable step	▼ 4%
Cash	€ 820,818 Cash 2022: € 820,818 First fiscal year in the series	€ 1,023,691 Cash 2023: € 1,023,691 ▲ 25% vs 2022 (€ 820,818) Favourable step	€ 1,175,409 Cash 2024: € 1,175,409 ▲ 15% vs 2023 (€ 1,023,691) Favourable step	€ 1,319,966 Cash 2025: € 1,319,966 ▲ 12% vs 2024 (€ 1,175,409) Favourable step	▲ 12%
Land & buildings	€ 476,849 Land & buildings 2022: € 476,849 First fiscal year in the series	€ 445,522 Land & buildings 2023: € 445,522 ▼ 7% vs 2022 (€ 476,849) Unchanged	€ 427,013 Land & buildings 2024: € 427,013 ▼ 4% vs 2023 (€ 445,522) Unchanged	€ 399,650 Land & buildings 2025: € 399,650 ▼ 6% vs 2024 (€ 427,013) Unchanged	▼ 6%
Retained profit	€ 1,097,429 Retained profit 2022: € 1,097,429 First fiscal year in the series	€ 1,339,336 Retained profit 2023: € 1,339,336 ▲ 22% vs 2022 (€ 1,097,429) Favourable step	€ 1,514,405 Retained profit 2024: € 1,514,405 ▲ 13% vs 2023 (€ 1,339,336) Favourable step	€ 1,832,325 Retained profit 2025: € 1,832,325 ▲ 21% vs 2024 (€ 1,514,405) Favourable step	▲ 21%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 24,500 Dividend 2023: € 24,500 Unchanged (€ 0) Unchanged	€ 125,500 Dividend 2024: € 125,500 ▲ € 101,000 vs 2023 (€ 24,500) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 125,500) Unchanged	▼ 100%
Bank debt	€ 230,420 Bank debt 2022: € 230,420 First fiscal year in the series	€ 197,942 Bank debt 2023: € 197,942 ▼ 14% vs 2022 (€ 230,420) Favourable step	€ 175,061 Bank debt 2024: € 175,061 ▼ 12% vs 2023 (€ 197,942) Favourable step	€ 155,205 Bank debt 2025: € 155,205 ▼ 11% vs 2024 (€ 175,061) Favourable step	▼ 11%
Balance sheet total	€ 1,424,373 Balance sheet total 2022: € 1,424,373 First fiscal year in the series	€ 1,612,521 Balance sheet total 2023: € 1,612,521 ▲ 13% vs 2022 (€ 1,424,373) Unchanged	€ 1,780,923 Balance sheet total 2024: € 1,780,923 ▲ 10% vs 2023 (€ 1,612,521) Unchanged	€ 2,089,432 Balance sheet total 2025: € 2,089,432 ▲ 17% vs 2024 (€ 1,780,923) Unchanged	▲ 17%

Key figures of Dr. DE CALUWE & ABURN, huisartsen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. DE CALUWE & ABURN, huisartsen?

What happened at Dr. DE CALUWE & ABURN, huisartsen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 18, 2026 New annual accounts for financial year 2025: profit of € 317,920 (▲ 6% vs 2024). Source: NBB ↗
2006 Gillian Aburn became a director. NBB
Jan 18, 2003 New establishment in Stekene. KBO
1992 Pieter De Caluwé became a director. NBB
Dec 22, 1992 Start of the company according to the CBE. KBO

In short

From € 189,737 profit in 2022 to € 317,920 profit in 2025.

Paid € 495,945 in corporate taxes since 2022.

Best year ever: 2025, with € 317,920 profit.

Paid out € 150,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Gillian Aburn Pieter De Caluwé

Dr. DE CALUWE & ABURN, huisartsen

Behind Dr. DE CALUWE & ABURN, huisartsen are Gillian Aburn and Pieter De Caluwé.

Directors

According to the 2025 annual accounts

Gillian Aburn

Director

since 2006

Pieter De Caluwé

Director

since 1992

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat(STE) 70

9190 Stekene

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0449.126.430

VAT number

BE 0449.126.430

Registered office

Dorpsstraat(STE) 70, 9190 Stekene

Names & denominations

Dr. DE CALUWE & ABURN, huisartsen

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 December 1992

Peppol

Active · Active since 29 Aug 2023

Activities · NACE

Activiteiten van huisartspraktijken

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. DE CALUWE & ABURN, huisartsen

Financials

What happened to Dr. DE CALUWE & ABURN, huisartsen?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions